Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

987
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
987
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

503
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
503
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

861
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
861
Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

1.4K
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
1.4K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

593
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
593
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

873
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
873

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of one avocado a day for six months on cognitive performance in overweight adults: A randomized controlled trial.

The journal of nutrition, health & aging·2026
Same author

Effects of Fermented Soy on Cognition in Older Adults: Outcomes of a Randomized, Controlled Trial.

Nutrients·2025
Same author

Identifying a next-generation antimalarial trioxolane in a landscape of artemisinin partial resistance.

Science advances·2025
Same author

Association of myeloid cell reactivity patterns with safe food predictions in FPIES patients.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology·2025
Same author

Comparison of continuous versus on-demand proton pump inhibitor therapy in symptom control of patients with Barrett's esophagus.

Journal of the Formosan Medical Association = Taiwan yi zhi·2025
Same author

Initial Diagnostic Strategies for Helicobacter Pylori in Patients With Bleeding Peptic Ulcers Undergoing Endoscopy: A Cost-Effectiveness Analysis.

Gastro hep advances·2025

Related Experiment Video

Updated: Mar 6, 2026

Tissue Engineering of the Intestine in a Murine Model
08:45

Tissue Engineering of the Intestine in a Murine Model

Published on: December 1, 2012

15.6K

Recent advances in pediatric celiac disease.

Grace J Lee1, John Y Kao2

  • 1a Division of Pediatric Gastroenterology, Department of Pediatrics and Communicable Diseases , C.S. Mott Children's Hospital, University of Michigan , Ann Arbor , MI , USA.

Expert Review of Gastroenterology & Hepatology
|March 21, 2017
PubMed
Summary

Recent studies show infant feeding practices like breastfeeding and gluten introduction timing do not significantly impact celiac disease (CD) risk. Microbiota alterations are observed in CD patients, but their role remains unclear.

Keywords:
Celiac diseasediagnosisinfant feeding practicesmicrobiotarisk factors

More Related Videos

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.4K
Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

610

Related Experiment Videos

Last Updated: Mar 6, 2026

Tissue Engineering of the Intestine in a Murine Model
08:45

Tissue Engineering of the Intestine in a Murine Model

Published on: December 1, 2012

15.6K
A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.4K
Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

610

Area of Science:

  • Pediatric Gastroenterology
  • Immunology
  • Microbiome Research

Background:

  • Celiac disease (CD) incidence has risen significantly.
  • Traditional diagnostic methods for CD involve duodenal biopsies.
  • Identifying CD risk factors is a growing area of research.

Purpose of the Study:

  • To review recent literature on infant feeding practices and microbiota in celiac disease development.
  • To evaluate the application of non-biopsy diagnostic guidelines for pediatric CD.
  • To explore potential biomarkers for CD diagnosis and prevention.

Main Methods:

  • Literature review of recent studies on infant feeding, microbiota, and CD.
  • Analysis of European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for non-biopsy CD diagnosis.
  • Discussion of preliminary data and ongoing prospective investigations.

Main Results:

  • Breastfeeding and gluten introduction timing show no significant effect on CD risk in at-risk populations.
  • Alterations in the gut microbiota are present in celiac disease patients.
  • Preliminary data supports a non-biopsy approach for diagnosing pediatric CD in certain populations.

Conclusions:

  • Infant feeding practices may not be primary drivers of celiac disease risk.
  • The role of the microbiome in CD pathogenesis requires further investigation.
  • Non-biopsy diagnostic strategies show promise for pediatric celiac disease, warranting further research.